Medical News Today

Subscribe to Medical News Today feed
Epilepsy is relatively common - it is a group of disorders that involve recurrent seizures. Epilepsy can start at any age, but it mostly begins during childhood. Treatment involves using epilepsy drugs to control seizures. In rare cases, surgery may be used to either remove a specific area of the brain that is affected, or install an electrical device to assist in controlling seizures.
Updated: 1 hour 19 min ago

Finding sheds light on what may kill neurons after stroke

Mon, 05/02/2016 - 04:00
Discovery paves the way for a highly specific drug target for strokes and brain injuries.
Categories: What's Current?

Salts in the brain control our sleep-wake cycle

Mon, 05/02/2016 - 04:00
Danish research is behind a new epoch-making discovery, which may prove decisive to future brain research. The level of salts in the brain plays a critical role in whether we are asleep or awake.
Categories: What's Current?

Brain signals between seizures may explain memory problems in patients with epilepsy

Tue, 04/26/2016 - 11:00
Study suggests how future devices might prevent cognitive deficits. Between seizures and continually, brain cells in epileptic patients send signals that make "empty memories," perhaps explaining...
Categories: What's Current?

Commanding, between-seizure brain signals may explain memory problems in patients with epilepsy

Mon, 04/25/2016 - 11:00
Between seizures and continually, brain cells in epileptic patients send signals that make "empty memories," perhaps explaining the learning problems faced by up to 40 percent of patients.
Categories: What's Current?

New neurodevelopmental syndrome identified

Fri, 04/22/2016 - 08:00
A multicenter research team led by Columbia University Medical Center (CUMC) has discovered a new neurodevelopmental syndrome and the genetic mutations that cause it.
Categories: What's Current?

Novartis drug Afinitor significantly reduces seizures in Phase III study of patients with tuberous sclerosis complex

Fri, 04/22/2016 - 07:00
Everolimus is the first adjunctive therapy shown in a prospective randomized Phase III study to achieve clinically significant seizure control in TSC patients1.
Categories: What's Current?

Researchers discover moving, electrically 'silent' source initiates brain waves

Thu, 04/21/2016 - 05:00
Finding may help in understanding memory formation, treating epilepsy. Brain waves that spread through the hippocampus are initiated by a method not seen before--a possible step toward...
Categories: What's Current?

Toward quieting the brain - promising anti-seizure strategies

Tue, 04/19/2016 - 12:00
Cluster Analysis of Cat Neural Networks Reveals Promising Anti-seizure Strategies.Chronic brain diseases such as epilepsy involve disturbances of the brain's electrical activity.
Categories: What's Current?

Women with epilepsy just as likely to get pregnant as healthy women of childbearing age

Mon, 04/18/2016 - 05:00
Women with epilepsy are just as likely to achieve a successful pregnancy as women without the neurological disorder, according to a new study led by research teams at multiple centers, including...
Categories: What's Current?

Once-a-day epilepsy drug may prevent seizures as well as twice-a-day drug

Thu, 04/14/2016 - 16:00
A new study suggests that an epilepsy drug that can be taken once a day may control seizures as well as a drug that must be taken twice a day, according to a preliminary study presented at the...
Categories: What's Current?

A common brain cell shapes the nervous system in unexpected ways

Tue, 04/12/2016 - 06:00
More than half of our brains are made up of glial cells, which wrap around nerve fibers and insulate them--similarly to how the plastic casing of an electric cable insulates the copper wire...
Categories: What's Current?

GW Pharmaceuticals initiates Phase 3 pivotal study in Tuberous Sclerosis Complex

Mon, 04/11/2016 - 11:00
GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, has announced that...
Categories: What's Current?

Epilepsy drug may not increase risk of birth defects

Wed, 04/06/2016 - 16:00
Babies born to pregnant women taking the epilepsy drug lamotrigine may not be at an increased risk of birth defects, such as cleft lip, cleft palate or clubfoot, according to a study published in...
Categories: What's Current?

Subclinical epileptic bursts in the brain may affect patients' driving

Tue, 04/05/2016 - 11:00
Epileptic discharges in the brain that are unaccompanied by obvious clinical signs are regarded as subclinical or interictal.
Categories: What's Current?

Penn study describes the molecular cause of common cerebrovascular disease

Thu, 03/31/2016 - 09:00
Cerebral cavernous malformations (CCMs) are clusters of dilated, thin-walled blood vessels in the brain that can cause stroke and seizures, yet exactly how they form is somewhat of a mystery.
Categories: What's Current?

Study finds birth control pills may increase risk of seizures in women with epilepsy

Thu, 03/31/2016 - 07:00
Could certain types of hormonal contraceptives cause an increase in seizures in women with epilepsy?
Categories: What's Current?

Pitt team redesigns epilepsy drug to increase potency and specificity, reduce side effects

Wed, 03/30/2016 - 12:00
Researchers at the University of Pittsburgh School of Medicine and Arts & Sciences have designed a more effective version of an FDA-approved epilepsy drug with the potential for fewer side effects...
Categories: What's Current?

Neuron type-specific gene loss linked to Angelman syndrome seizures

Mon, 03/28/2016 - 03:00
The gene UBE3A plays a critical role in early neurological development. If UBE3A is overexpressed - or if the enzymatic function of UBE3A protein is hyperactive - autism ensues.
Categories: What's Current?

People with epilepsy fear discrimination according to national charity poll

Thu, 03/24/2016 - 12:00
Many people with epilepsy don't feel comfortable talking about their condition for fear they will be discriminated against, according to a charity poll.
Categories: What's Current?

Epilepsy: first FDA-approved medicine manufactured using 3D printing technology now available

Thu, 03/24/2016 - 09:00
Aprecia Pharmaceuticals has announced that SPRITAM® (levetiracetam) tablets, for oral suspension, is now available as an adjunctive therapy in the treatment of partial onset seizures, myoclonic...
Categories: What's Current?

Pages